What is new for resveratrol? Is a new set of recommendations necessary?

Annals of the New York Academy of Sciences

Volumn 1290, Issue 1, 2013, Pages 1-11

  Vang, Ole ^a  

^a ROSKILDE UNIVERSITY   (Denmark)

Author keywords

Clinical trials; Human health; Human use; Resveratrol

Indexed keywords

CURCUMIN; GENISTEIN; LONGEVINEX; POLYGONUM CUSPIDATUM EXTRACT; QUERCETIN; RESVERATROL; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; BIOLOGICAL ACTIVITY; CANCER PATIENT; CARDIOVASCULAR DISEASE; CELL PROLIFERATION; COLORECTAL CANCER; CROSSOVER PROCEDURE; DENMARK; DIABETES MELLITUS; DIET SUPPLEMENTATION; DIETARY INTAKE; DISEASE COURSE; DRUG EFFECT; HEALTH PROMOTION; HUMAN; INFLAMMATION; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; LIVER METASTASIS; LONG TERM EXPOSURE; MEDICAL SOCIETY; METABOLIC SYNDROME X; MUSCLE INJURY; NONHUMAN; OBESITY; OPEN STUDY; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); SINGLE DRUG DOSE; UNSPECIFIED SIDE EFFECT;

EID: 84880392788     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/nyas.12173     Document Type: Article

References (40)

1. Takaoka, M. 1939. Resveratrol, a new phenolic compound from Veratrum grandiflorum. Nippon Kagaku Kaichi 60: 1090-1100.
2. Arichi, H., Y. Kimura, H. Okuda, et al. 1982. Effects of stilbene components of the roots of Polygonum cuspidatum Sieb. et Zucc. on lipid metabolism. Chem. Pharm. Bull. 30: 1766-1770.
3. Siemann, E.H. & L.L. Creasy. 1992. Concentration of the phytoalexin resveratrol in wine. Amer. J. Enol. Viticult. 43: 49-52.
4. Frankel, E.N., A.L. Waterhouse & J.E. Kinsella. 1993. Inhibition of human LDL oxidation by resveratrol. Lancet 341: 1103-1104.
5. Jang, M., L. Cai, G.O. Udeani, et al. 1997. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275: 218-220.
6. Howitz, K.T., K.J. Bitterman, H.Y. Cohen, et al. 2003. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 425: 191-196.
7. Baur, J. A., K.J. Pearson, N.L. Price, et al. 2006. Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444: 337-342.
8. Lagouge, M., C. Argmann, Z. Gerhart-Hines, et al. 2006. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 127: 1109-1122.
9. Wattenberg, L.W. & W.D. Loub. 1978. Inhibition of polycyclic aromatic hydrocarbon-induced neoplasia by naturally occurring indoles. Cancer Res. 38: 1410-1413.
10. Stakleff, K.S., T. Sloan, D. Blanco, et al. 2012. Resveratrol exerts differential effects in vitro and in vivo against ovarian cancer cells. Asian Pac. J. Cancer Prev. 13: 1333-1340.
11. Vang, O., N. Ahmad, C.A. Baile, et al. 2011. What is new for an old molecule? Systematic review and recommendations on the use of resveratrol. PLoS ONE 6: e19881.
12. Williams, L.D., G.A. Burdock, J.A. Edwards, et al. 2009. Safety studies conducted on high-purity trans-resveratrol in experimental animals. Food Chem. Toxicol. 49: 2170-2182.
13. Brasnyo, P., G.A. Molnar, M. Mohas, et al. 2011. Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients. Br. J. Nutr. 106: 383-389.
14. Magyar, K., R. Halmosi, A. Palfi, et al. 2012. Cardioprotection by resveratrol: a human clinical trial in patients with stable coronary artery disease. Clin. Hemorheol. Microcirc. 50: 179-187.
15. Brown, V.A., K.R. Patel, M. Viskaduraki, et al. 2010. Repeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers: safety, pharmacokinetics, and effect on the insulin-like growth factor axis. Cancer Res. 70: 9003-9011.
16. Howells, L.M., D.P. Berry, P.J. Elliott, et al. 2011. Phase I randomised double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases-safety, pharmacokinetics andpharmacodynamics. Cancer Prev. Res. 4: 1419-1425.
17. O'Connor, P.J., A.L. Caravalho, E.C. Freese & K.J. Cureton. 2013. Grape consumption effects on fitness, muscle injury, mood and perceived health. Int. J. Sport Nutr. Exerc. Metab. 23: 57-64.
18. Kennedy, D.O., E.L. Wightman, J.L. Reay, et al. 2010. Effects of resveratrol on cerebral blood flow variables and cognitive performance in humans: a double-blind, placebo-controlled, crossover investigation. Am. J. Clin. Nutr. 91: 1590-1597.
19. Wong, R.H.X., P.R.C. Howe, J.D. Buckley, et al. 2011. Acute resveratrol supplementation improves flow-mediated dilatation in overweight/obese individuals with mildly elevated blood pressure. Nutr. Metab. Cardiovasc. Dis. 21: 851-856.
20. Heger, A., F. Ferk, A. Nersesyan, et al. 2012. Intake of a resveratrol-containing dietary supplement has no impact on DNA stability in healthy subjects. Mutat. Res. 749: 82-86.
21. Patel, K.R., V.A. Brown, D.J. Jones, et al. 2010. Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients. Cancer Res. 70: 7392-7399.
22. Tome-Carneiro, J., M. Gonzalvez, M. Larrosa, et al. 2012. Consumption of a grape extract supplement containing resveratrol decreases oxidized LDL and ApoB in patients undergoing primary prevention of cardiovascular disease: A triple-blind, 6-month follow-up, placebo-controlled, randomized trial. Mol. Nutr. Food Res. 56: 810-821.
23. Timmers, S., E. Konings, L. Bilet, et al. 2011. Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans. Cell Metab. 14: 612-622.
24. Crandall, J.P., V. Oram, G. Trandafirescu, et al. 2010. Resveratrol improves glucose metabolism in older adults with IGT [abstract]. Diabetes 59: A201.
25. Militaru, C., I. Donoiu, A. Craciun, et al. 2013. Oral resveratrol and calcium fructoborate supplementation in subjects with stable angina pectoris: effects on lipid profiles, inflammation markers, and quality of life. Nutrition 29: 178-183.
26. Yoshino, J., C. Conte, L. Fontana, et al. 2012. Resveratrol supplementation does not improve metabolic function in nonobese women with normal glucose tolerance. Cell Metab. 15: 658-664.
27. Poulsen, M.M., P.F. Vestergaard, B.F. Clasen, et al. 2013. High-dose resveratrol supplementation in obese men: an investigator-initiated, randomized, placebo-controlled clinical trial of substrate metabolism, insulin sensitivity, and body composition. Diabetes DOI: 10.2337/db12-0975.
28. Chow, H.H., L.L. Garland, C.H. Hsu, et al. 2010. Resveratrol modulates drug- and carcinogen-metabolizing enzymes in a healthy volunteer study. Cancer Prev. Res. 3: 1168-1175.
29. Fabbrocini, G., S. Staibano, G. De Rosa, et al. 2011. Resveratrol-containing gel for the treatment of acne vulgaris: a single-blind, vehicle-controlled, pilot study. Am. J. Clin. Dermatol. 12: 133-141.
30. Ghanim, H., C.L. Sia, K. Korzeniewski, et al. 2011. A resveratrol and polyphenol preparation suppresses oxidative and inflammatory stress response to a high-fat, high-carbohydrate meal. J. Clin. Endocrinol. Metab. 96: 1409-1414.
31. Fujitaka, K., H. Otani, F. Jo, et al. 2011. Modified resveratrol Longevinex improves endothelial function in adults with metabolic syndrome receiving standard treatment. Nutr. Res. 31: 842-847.
32. Tome-Carneiro, J., M. Gonzalvez, M. Larrosa, et al. 2012. One-year consumption of a grape nutraceutical containing resveratrol improves the inflammatory and fibrinolytic status of patients in primary prevention of cardiovascular disease. Am. J. Cardiol. 110: 356-363.
33. Buonocore, D., A. Lazzeretti, P. Tocabens, et al. 2012. Resveratrol-procyanidin blend: nutraceutical and antiaging efficacy evaluated in a placebocontrolled, double-blind study. Clin Cosmet. Investig. Dermatol. 5: 159-165.
34. Nguyen, A.V., M. Martinez, M.J. Stamos, et al. 2009. Results of a phase I pilot clinical trial examining the effect of plant-derived resveratrol and grape powder on Wnt pathway target gene expression in colonic mucosa and colon cancer. Cancer Manag. Res. 1: 25-37.
35. Shufelt, C., C.N. Merz, Y. Yang, et al. 2012. Red versus white wine as a nutritional aromatase inhibitor in premenopausal women: a pilot study. J. Womens Health (Larchmt.) 21: 281-284.
36. Martinez, M., C. Hope, K. Planutis, et al. 2010. Dietary grape-derived resveratrol for colon cancer prevention [abstract]. J. Clin. Oncol. 28, 15S, Abstr. 3622.
37. Ghanim, H., C.L. Sia, S. Abuaysheh, et al. 2010. An antiinflammatory and reactive oxygen species suppressive effects of an extract of Polygonum cuspidatum containing resveratrol. J. Clin. Endocrinol. Metab. 95: E1-E8.
38. Bakker, G.C.M., M.J. van Erk, L. Pellis, et al. 2010. An antiinflammatory dietary mix modulates inflammation and oxidative and metabolic stress in overweight men: a nutrigenomics approach. Am. J. Clin. Nutr. 91: 1044-1059.
39. De Groote, D., K. Van Belleghem, J. Deviere, et al. 2012. Effect of the intake of resveratrol, resveratrol phosphate, and catechin-rich grape seed extract on markers of oxidative stress and gene expression in adult obese subjects. Ann. Nutr. Metab. 61: 15-24.
40. Chiva-Blanch, G., M. Urpi-Sarda, R. Llorach, et al. 2012. Differential effects of polyphenols and alcohol of red wine on the expression of adhesion molecules and inflammatory cytokines related to atherosclerosis: a randomized clinical trial. Am. J. Clin. Nutr. 95: 326-334.